Social Media Ideas for Atai

AtaiBeckley: 'Hold'; Eli Lilly Acquisition For $2.8 Billion Adds To Its Neuroscience Pipeline

UBS reiterates Eli Lilly stock rating on ATAI acquisition

Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion

Today, July 16, 2026, the clinical-stage psychedelics developer jumped 33% after Lilly announced a cash deal plus milestone payments.

Action for A-T

http://www.actionforat.org/ Twitter: @actionforAT Primary research areas Neurological Additional research areas Cancer, Respiratory, Inflammatory and i...

Pα+ Psychedelic Bulletin #228: Inside the Lilly-Atai Deal; An Update on the GH-AtaiBeckley Patent Standoff; Field Reacts...

Inside the Lilly-Atai Deal, and a Patent Standoff with GH Research Getting anyone familiar with the specifics surrounding the Eli Lilly-AtaiBeckley deal to go on the record has bee...

Atour (ATAT) Q2 2026 Earnings Call Transcript

Net revenues surged 41.4% year-over-year as retail and hotel expansion accelerated.

Why AtaiBeckley Stock Soared Today

The psychedelic drugmaker is being acquired.

ATN International, Inc. 2026 Q2 - Results - Earnings Call Presentation

Lilly Expands Its Mind to Psychedelics With $2.8B AtaiBeckley Acquisition

Eli Lilly’s AtaiBeckley acquisition marks a dozen M&A deals for the pharma company so far this year. AtaiBeckley’s lead program is an intranasally administered psychedelic drug...

Breaking: World’s Largest Pharmaceutical Company, Eli Lilly, Acquires 5-MeO-DMT Developer AtaiBeckley for Up to $3.8 bil...

<![CDATA[Eli Lilly to Acquire AtaiBeckley for $2.8 Billion ]]>

Ataxia-Telangiectasia Society

http://www.atsociety.org.uk/ Twitter: @ATSociety Primary research areas Cancer,  Inflammatory and immune system,  Metabolic and endocrine,  Neurological,  Respiratory Grant typ...

Are ATAI, FHB, PATK Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

Atmus Filtration Technologies Inc. 2026 Q2 - Results - Earnings Call Presentation

ATEC Announces Participation in Upcoming Investor Conferences

CARLSBAD, Calif., July 27, 2026 -(BUSINESS WIRE)- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated…

Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market

Eli Lilly has struck a deal to buy AtaiBeckley for $2.8 billion upfront, continuing its takeover spree to move into a psychedelic mental health sector targeted by companies includi...

StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley a Good Trip for Psychedelic Drugs, Analysts and Investors Agree

Eli Lilly agreed to acquire AtaiBeckley for up to $3.8 billion—of which Lilly will pay $2.8 billion upfront. The deal, set to close in the third quarter, expands Lilly’s neuroscien...

Echodyne Announces ATAK Integration for MESA Radar Platform

Integration enables Echodyne MESA radars to support ATAK-based operational workflows Echodyne, the radar platform company, today announced the availability of an Android Team Aware...

AXT: AI Driven InP Demand Makes The Valuation Worth The Risk

Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3 trial

Atea Pharmaceuticals’ hepatitis C prospect has matched Gilead’s Epclusa in a phase 3 trial, keeping the biotech barreling toward a second readout for its shorter, simpler treatment...

Pα+ Psychedelic Bulletin #229: SAMHSA Convenes Experts; AtaiBeckley’s Road to Lilly; Turnbull Doubles Down on BOL-148; C...

SAMHSA Convenes Experts to Tackle Psychedelic Data Gaps Dozens of experts met in D.C. last week under the auspices of SAMHSA’s two-day consultation, titled ‘Addressing Data Gaps to...

Ataxia UK

www.ataxia.org.uk Twitter: @AtaxiaUK Primary research areas Neurological Additional research areas Cardiovascular,  Ear,  Inflammatory and immune system,  Mental health Grant...

ATR Stop Indicator MT4

The underlying idea comes from the Average True Range developed by J. Welles Wilder. ATR measures the average size of recent price ranges, including gaps where applicable. A common...

IMA sells majority stake in electric motor equipment maker ATOP to Lichtenberg Capital

IMA Group has agreed to sell a majority stake in ATOP, an Italian builder of automated production lines and winding machines for electric motor stators and rotors, to a vehicle adv...